A 35-year-old pregnant woman considering maternal serum screening and amniocentesis

JAMA

Volumn 275, Issue 18, 1996, Pages 1440-1446

  Mennuti, Michael ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; MERCAPTOPURINE;

ADULT; AMNIOCENTESIS; CASE REPORT; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; COLITIS; CONFERENCE PAPER; COUNSELING; DOWN SYNDROME; ECHOGRAPHY; FEMALE; HUMAN; MATERNAL AGE; MATERNAL SERUM; NEURAL TUBE DEFECT; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

EID: 0029950944     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.18.1440     Document Type: Conference Paper

References (24)

1. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. MMWR Morb Mortal Wkly Rep. July 21, 1995;44(No. RR-9):1-12.
2. Verp MS. Prenatal diagnosis and genetic disorders. In: Gleicher N, ed. Principles and Practice of Medical Therapies in Pregnancy. 2nd ed. Norwalk, Conn: Appleton Lange; 1992:159-170.
3. Evans JA, Hamerton JL. Limb defects and chorionic villus sampling. Lancet. 1996;347:484-485.
4. The New England Regional Genetics Group Collaborative Study of Down Syndrome Screening. Combining maternal serum alpha-fetoprotein measurements and age to screen for Down syndrome in pregnant women under age 35. Am. J Obstet Gynecol. 1989;160:575-581.
5. Rose NC, Palomaki GE, Haddow JE, et al. Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women age 35 and older. Am J Obstet Gynecol. 1994;170:1073-1080.
6. Chard T, Lowings C, Kitau MJ. Alpha-fetoprotein and chorionic gonadotropin levels in relation to Down's syndrome. Lancet. 1984;2:750.
7. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7:623-630.
8. Canick JA, Knight GJ, Palomaki GE, et al. Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obestet Gynaecol. 1988;95:330-333.
9. Wald NJ, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ. 1988;297:883-887.
10. Phillips OP, Elias S, Shulman LP, et al. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2 year study. Obstet Gynecol. 1992;80:353-358.
11. Haddow JE, Palomaki GE, Knight GJ, et al. Prenatal screening of Down's syndrome using maternal serum markers. N Engl J Med. 1992;327:588-593.
12. American College of Obstetricians and Gynecologists. Committee Opinion No. 141: Down Syndrome Screening. Washington, DC: American College of Obstetricians and Gynecologists; 1994.
13. Haddow JE, Palomaki GE, Knight GJ, et al. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med. 1994;330:1114-1118.
14. Canick JA, Palomaki GE, Osathanondh R. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990;10:546-548.
15. Rose NC, Mennuti MT. Alpha-fetoprotein and neural tube defects. In: Sciarra JJ, ed. Gynecology and Obstetrics, V. Philadelphia, Pa: Harper & Row; 1993:1-14.
16. Merkatz IR, Nitowsky HM, Macri JN, et al. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148:886-894.
17. Ferguson-Smith MA, Yates JRW. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a European collaborative study on amniocentesis. Prenat Diagn. 1984;4:5-44.
18. Robinson A, Bender BG, Linden MG. Decisions following the intrauterine diagnosis of sex chromosome aneuploidy. Am J Med Genet. 1989;34:552-554.
19. Holmes-Siedle M, Ryynanen M, Lindenbaum RH. Parental decisions regarding termination of pregnancy following prenatal detection of sex chromosome abnormality. Prenat Diagn. 1987;7:239-244.
20. Cheng EY, Luthy DA, Zebelman AM, et al. A prospective evaluation of a second trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol. 1993;81:72-77.
21. Beekhuis JR, De Wolf BTHM, Mantingh A, Heringa MP. The influence of serum screening on the amniocentesis rate in women of advanced maternal age. Prenat Diagn. 1994;14:199-202.
22. Atrash HK, MacKay T, Binkin NJ, et al. Legal abortion mortality in the United States: 1972-1982. Am J Obstet Gynecol. 1987;156:605-612.
23. Rose NC, Mennuti MT. Periconceptual folic acid supplementation as a social intervention. Semin Perinatal. 1995;19:243-254.
24. American College of Medical Genetics. Statement on guidance for genetic counseling in advanced paternal age. Guidance Genet Counseling Adv Paternal Age Newslett. 1996;6:13.